Skip to main content
All lobbying filings

FERRING PHARMACEUTICALS, INC.

FERRING PHARMACEUTICALS, INC. filed a Q2 report for FERRING PHARMACEUTICALS, INC. on July 18, 2025.

Lobbying for FERRING PHARMACEUTICALS, INC.

All filings by FERRING PHARMACEUTICALS, INC. · Everything FERRING PHARMACEUTICALS, INC. has reported

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jul 18, 2025
Expenses
$160,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
District of Columbia

Official filing document

 Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 2

Issues related to fertility treatment and coverage (no bill); issues related to federal employee health care coverage (no bill) issues related to veteran health care coverage (no bill); issues related to military health care coverage (no bill); issues related to Medicare physician fee schedule and Orphan Cures (To provide for reconciliation pursuant to title II of H. Con. Res. 14 (H.R. 1 / no Senate bill number)).

Issues related to establishing a tax credit for fertility treatments (IVF Access and Affordability Act, H.R. 1878 / no Senate bill); issues related to taxation of foreign businesses (To provide for reconciliation pursuant to title II of H. Con. Res. 14 (H.R. 1 / no Senate bill number)).

 Bills named in this filing 3
  • H. Con. Res. 14
    Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appro…
  • H.R. 1
    One Big Beautiful Bill Act
  • H.R. 1878
    IVF Access and Affordability Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem